Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Lyrica® (pregabalin) – Expanded indication
May 3, 2018 - The FDA approved Pfizer’s Lyrica (pregabalin), for adjunctive therapy for the treatment of partial onset seizures in patients 4 years of age and older.
